2021
DOI: 10.1016/j.mpdhp.2020.10.009
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous vasculitis

Abstract: Cutaneous vasculitides are inflammatory diseases starting at and evolving around the blood vessels of the skin. They should be separated from occluding vasculopathies, where the pathological process predominantely starts in the blood. They can be graded according to their relationship to systemic vasculitides as a cutaneous component of a systemic vasculitis, as a skin-dominant variant of a systemic vasculitis or as a cutaneous single organ vasculitis. Diagnostic measures, therapy and prognoses depend greatly … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…Second, some authors do not clearly distinguish between primary vasculitis and coagulopathy which has important therapeutic consequences ( 41 , 42 ); classical vasculitides are treated with the immunosuppressive agents; microorganism-associated vasculitides need specific antimicrobial therapy; and coagulopathies require anticoagulants. Third, vasculitides can present a relatively benign single-organ (e.g., cutaneous) disease or systemic disease with an impaired prognosis ( 13 , 21 23 , 27 , 43 , 44 ). The different tissues from organ to organ lead to varying pathologic processes (e.g., hemorrhage is a common manifestation in the affected loose tissue of the lung; or the accumulation of capillary loops makes glomeruli a predisposed area for vascular disease, most commonly seen in leukocytoclastic vasculitis) impeding a precise comparison of morphologic findings ( 12 ).…”
Section: Discussionmentioning
confidence: 99%
“…Second, some authors do not clearly distinguish between primary vasculitis and coagulopathy which has important therapeutic consequences ( 41 , 42 ); classical vasculitides are treated with the immunosuppressive agents; microorganism-associated vasculitides need specific antimicrobial therapy; and coagulopathies require anticoagulants. Third, vasculitides can present a relatively benign single-organ (e.g., cutaneous) disease or systemic disease with an impaired prognosis ( 13 , 21 23 , 27 , 43 , 44 ). The different tissues from organ to organ lead to varying pathologic processes (e.g., hemorrhage is a common manifestation in the affected loose tissue of the lung; or the accumulation of capillary loops makes glomeruli a predisposed area for vascular disease, most commonly seen in leukocytoclastic vasculitis) impeding a precise comparison of morphologic findings ( 12 ).…”
Section: Discussionmentioning
confidence: 99%